DrugId:  1
1. Name:  Ganitumab
2. Groups:  Investigational
3. Description:  Ganitumab has been used in trials studying the treatment of Colon Cancer, Rectal Cancer, Breast Cancer, Breast Tumors, and Breast Neoplasms, among others.
4. Indication:  Not Available
DrugId:  2
1. Name:  Figitumumab
2. Groups:  Investigational
3. Description:  Figitumumab has been used in trials studying the treatment of Sarcoma, Solid Tumor, Breast Cancer, Lung Neoplasms, and Advanced Cancer, among others.
4. Indication:  Not Available
DrugId:  3
1. Name:  Fluoxymesterone
2. Groups:  Approved, Illicit
3. Description:  An anabolic steroid that has been used in the treatment of male hypogonadism, delayed puberty in males, and in the treatment of breast neoplasms in women. [PubChem]
4. Indication:  In males, used as replacement therapy in conditions associated with symptoms of deficiency or absence of endogenous testosterone. In females, for palliation of androgenresponsive recurrent mammary cancer in women who are more than one year but less than five years postmenopausal.
DrugId:  4
1. Name:  Lumretuzumab
2. Groups:  Investigational
3. Description:  Lumretuzumab has been used in trials studying the treatment of Neoplasms, Breast Cancer, Squamous Non-Small Cell Lung Cancer, and Non-Squamous Non-Small Cell Lung Cancer.
4. Indication:  Not Available
DrugId:  5
1. Name:  Atamestane
2. Groups:  Investigational
3. Description:  Atamestane has been used in trials studying the treatment of Breast Cancer, Breast Neoplasms, and Neoplasms, Hormone-Dependent.
4. Indication:  Not Available
DrugId:  6
1. Name:  5-fluoro-2'-deoxycytidine
2. Groups:  Investigational
3. Description:  5-fluoro-2'-deoxycytidine has been used in trials studying the treatment of Neoplasms, Lung Neoplasms, Breast Neoplasms, Head and Neck Neoplasms, and Urinary Bladder Neoplasms, among others.
4. Indication:  Not Available
DrugId:  7
1. Name:  Sapitinib
2. Groups:  Investigational
3. Description:  Sapitinib has been used in trials studying the treatment and basic science of Neoplasms, Breast Cancer, Breast Neoplasms, Metastatic Cancer, and Metastatic Breast Cancer, among others.
4. Indication:  Not Available
DrugId:  8
1. Name:  Tetrahydrouridine
2. Groups:  Investigational
3. Description:  Tetrahydrouridine has been used in trials studying the treatment of Neoplasms, Lung Neoplasms, Breast Neoplasms, Sickle Cell Disease, and Head and Neck Cancer, among others.
4. Indication:  Not Available
DrugId:  9
1. Name:  Larotaxel
2. Groups:  Investigational
3. Description:  Larotaxel has been used in trials studying the treatment of Cancer, Metastases, Breast Cancer, Breast Neoplasms, and Pancreatic Neoplasms, among others.
4. Indication:  Not Available
DrugId:  10
1. Name:  PF-04691502
2. Groups:  Investigational
3. Description:  PF-04691502 has been used in trials studying the treatment of Cancer, Breast Neoplasms, Early Breast Cancer (Phase 2), and Advanced Breast Cancer (Phase 1b).
4. Indication:  Not Available
DrugId:  11
1. Name:  CPG-52852
2. Groups:  Investigational
3. Description:  852A has been used in trials studying the treatment of Melanoma, Neoplasms, Breast Cancer, Ovarian Cancer, and Cervical Cancer, among others.
4. Indication:  Not Available
DrugId:  12
1. Name:  CP-724714
2. Groups:  Investigational
3. Description:  CP-724,714 has been used in trials studying the treatment of Breast Cancer, Breast Neoplasms, and Neoplasm Metastasis.
4. Indication:  Not Available
DrugId:  13
1. Name:  CI-1040
2. Groups:  Investigational
3. Description:  CI-1040 has been used in trials studying the treatment of Lung Cancer, Breast Cancer, Breast Neoplasms, Pancreatic Cancer, and Colorectal Cancer, among others.
4. Indication:  Not Available
DrugId:  14
1. Name:  Pertuzumab
2. Groups:  Approved
3. Description:  Pertuzumab is a recombinant humanized monoclonal antibody that targets the extracellular dimerization domain (Subdomain II) of the human epidermal growth factor receptor 2 protein (HER2). It consists of two heavy chains and two lights chains that have 448 and 214 residues respectively. FDA approved June 8, 2012.
4. Indication:  Pertuzumab is indicated for use in combination with trastuzumab and docetaxel for the treatment of patients with HER2-positive metastatic breast cancer who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.
DrugId:  15
1. Name:  Sagopilone
2. Groups:  Investigational
3. Description:  Sagopilone has been used in trials studying the treatment of Melanoma, Neoplasms, CNS Disease, Breast Cancer, and Breast Neoplasms, among others. It is a so-called fully synthetic epothilone and is the first such compound to be in clinical development to combat several forms of cancer. Epothilones are 16-member ring macrolides with antimicrotubule activity that share a similar mechanism of action to the taxanes but have demonstrated potent antiproliferative activity in several different multidrug-resistant and paclitaxel-resistant tumor cell lines in vitro and in vivo.
4. Indication:  Not Available
DrugId:  16
1. Name:  Drostanolone
2. Groups:  Approved, Illicit
3. Description:  Drostanolone (also known as dromostanolone) is a potent synthetic androgenic anabolic steroid similar to testosterone. Drostanolone is indicated in postmenopausal women with recurrent breast cancer, in a combined hormone therapy.
4. Indication:  For use in females, for palliation of androgenresponsive recurrent mammary cancer in women who are more than one year but less than five years postmenopausal.
DrugId:  17
1. Name:  Ipatasertib
2. Groups:  Investigational
3. Description:  Ipatasertib has been used in trials studying the treatment of Cancer, Neoplasms, Solid Cancers, Breast Cancer, and Gastric Cancer, among others.
4. Indication:  Not Available
DrugId:  18
1. Name:  LY-3039478
2. Groups:  Investigational
3. Description:  LY3039478 has been used in trials studying the treatment and basic science of LYMPHOMA, Neoplasms, Solid Tumor, COLON CANCER, and BREAST CANCER, among others.
4. Indication:  Not Available
DrugId:  19
1. Name:  AUY922
2. Groups:  Investigational
3. Description:  AUY922 has been used in trials studying the treatment of Lymphoma, Breast Cancer, Metastatic Disease, Advanced Solid Tumors, and Hematologic Neoplasms, among others.
4. Indication:  Not Available
DrugId:  20
1. Name:  PD-0325901
2. Groups:  Investigational
3. Description:  PD-0325901 has been used in trials studying the treatment and basic science of Melanoma, Solid Tumour, Solid Tumors, Advanced Cancer, and Breast Neoplasms, among others.
4. Indication:  Not Available
DrugId:  21
1. Name:  Alpelisib
2. Groups:  Investigational
3. Description:  Alpelisib has been used in trials studying the treatment and basic science of Neoplasms, Solid Tumors, BREAST CANCER, 3rd Line GIST, and Rectal Cancer, among others.
4. Indication:  Not Available
DrugId:  22
1. Name:  LCL-161
2. Groups:  Investigational
3. Description:  LCL161 has been used in trials studying the treatment of Leukemia, Neoplasms, Solid Tumors, Breast Cancer, and Ovarian Cancer, among others.
4. Indication:  Not Available
DrugId:  23
1. Name:  Foretinib
2. Groups:  Investigational
3. Description:  Foretinib has been used in trials studying the treatment of Cancer, Breast Cancer, Carcinoma, Renal Cell, Recurrent Breast Cancer, and Neoplasms, Head and Neck, among others. Foretinib is an orally available small molecule compound designed to target multiple RTKs implicated in the development, progression and spread of cancer. It inhibits the activation of MET, RON, ERK and AKT, decreased proliferation and increased apoptosis.
4. Indication:  Not Available
DrugId:  24
1. Name:  BCG vaccine
2. Groups:  Investigational
3. Description:  BCG vaccine has been investigated for the treatment of Neoplasms, Bladder Cancer, Neoplasms by Site, Urologic Diseases, and Urologic Neoplasms, among others.
4. Indication:  Not Available
DrugId:  25
1. Name:  Etarfolatide
2. Groups:  Investigational
3. Description:  Etarfolatide has been used in trials studying the treatment and diagnostic of Breast Neoplasms, Non Small Cell Lung Cancer, and Adenocarcinoma of the Lung.
4. Indication:  Not Available
